LQDA
Liquidia Corporation NASDAQ Listed Jul 26, 2018$83.85
-0.31%
vs $84.11
Mkt Cap $7.2B
52w Low $17.68
92.7% of range
52w High $89.03
50d MA $73.69
200d MA $45.24
P/E (TTM)
602.8x
EV/EBITDA
133.1x
P/B
161.2x
Debt/Equity
4.4x
ROE
-154.0%
P/FCF
-180.3x
RSI (14)
61.10
ATR (14)
$5.50
Beta
0.46
50d MA
$73.69
200d MA
$45.24
Avg Volume
1.6M
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
419 Davis Drive · Morrisville, NC 27560 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | TNS | 0.41 | 0.52 | +26.8% | 53.13 | +1.3% | +6.5% | +1.7% | +3.0% | -4.0% | +0.1% | — |
| Mar 5, 2026 | TNS | 0.08 | 0.15 | +87.5% | 34.52 | +0.4% | +4.4% | -0.4% | +8.3% | -0.7% | -2.5% | — |
| Nov 3, 2025 | TNS | -0.45 | -0.04 | +91.1% | 25.22 | -1.9% | +10.7% | -5.3% | -3.1% | +1.9% | +4.5% | — |
| Aug 12, 2025 | TNS | -0.43 | -0.49 | -14.0% | 24.10 | +3.1% | +4.6% | +3.5% | -0.5% | +6.8% | -2.2% | — |
| May 8, 2025 | TNS | -0.42 | -0.45 | -7.1% | 15.35 | +1.2% | -0.6% | +3.2% | +1.5% | +16.6% | +3.5% | — |
| Mar 19, 2025 | TNS | -0.38 | -0.46 | -21.1% | 14.92 | -2.5% | +3.5% | -2.1% | +3.6% | -0.4% | -4.7% | — |
| Nov 13, 2024 | TNS | -0.37 | -0.37 | +0.0% | 10.27 | +0.4% | -2.3% | -1.9% | -0.2% | +3.5% | -0.4% | — |
| Aug 7, 2024 | TNS | -0.35 | -0.37 | -5.7% | 10.68 | +1.3% | +6.6% | +2.4% | +4.8% | +8.8% | +3.4% | — |
| May 13, 2024 | TNS | -0.32 | -0.54 | -68.8% | 12.14 | -1.6% | -1.5% | +2.8% | +3.7% | -0.2% | +5.0% | — |
| Mar 13, 2024 | TNS | -0.23 | -0.42 | -82.6% | 14.73 | +2.5% | +4.0% | +3.8% | -2.1% | +3.0% | -0.7% | — |
| Nov 7, 2023 | TNS | -0.20 | -0.24 | -20.0% | 6.80 | -1.3% | -4.5% | -5.6% | +2.3% | +0.9% | +0.9% | — |
| Aug 10, 2023 | TNS | -0.17 | -0.36 | -111.8% | 7.89 | -1.0% | -9.1% | -2.1% | -0.7% | -0.7% | -2.2% | — |
| May 4, 2023 | AMC | -0.18 | -0.18 | +0.0% | 7.32 | +1.4% | +1.1% | +2.7% | +0.0% | -1.7% | -2.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 | BofA Securities | Downgrade | Buy → Neutral | $79 | $78.17 | $76.80 | -1.8% | -3.9% | +6.1% | -0.5% | -0.5% | +0.4% |
| Aug 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.63 | $9.64 | +0.1% | +3.5% | -1.4% | -1.8% | -1.1% | +0.0% |
| Aug 22 | Needham | Maintains | Buy → Buy | — | $9.98 | $9.97 | -0.1% | -3.5% | +3.5% | -1.4% | -1.8% | -1.1% |
| Aug 20 | BofA Securities | Maintains | Buy → Buy | — | $9.79 | $9.67 | -1.2% | -1.9% | +4.0% | -3.5% | +3.5% | -1.4% |
| Aug 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.79 | $9.67 | -1.2% | -1.9% | +4.0% | -3.5% | +3.5% | -1.4% |
| Aug 20 | BTIG | Maintains | Buy → Buy | — | $9.79 | $9.67 | -1.2% | -1.9% | +4.0% | -3.5% | +3.5% | -1.4% |
| Aug 19 | Needham | Maintains | Buy → Buy | — | $14.11 | $8.95 | -36.6% | -30.6% | -1.9% | +4.0% | -3.5% | +3.5% |
| Aug 19 | BTIG | Maintains | Buy → Buy | — | $14.11 | $8.95 | -36.6% | -30.6% | -1.9% | +4.0% | -3.5% | +3.5% |
| Aug 19 | Raymond James | Upgrade | Outperform → Strong Buy | — | $14.11 | $8.95 | -36.6% | -30.6% | -1.9% | +4.0% | -3.5% | +3.5% |
| Aug 13 | Needham | Maintains | Buy → Buy | — | $12.21 | $12.28 | +0.6% | +8.8% | +3.4% | +0.7% | +2.0% | -30.6% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $10.68 | $10.82 | +1.3% | +6.6% | +2.4% | +4.8% | +8.8% | +3.4% |
| Jul 18 | Needham | Maintains | Buy → Buy | — | $11.34 | $11.40 | +0.5% | -3.1% | +0.8% | +2.5% | +1.7% | -1.8% |
| Jul 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.63 | $12.63 | +0.0% | -1.0% | -0.2% | +1.1% | -1.3% | +3.1% |
| Jun 3 | Needham | Maintains | Buy → Buy | — | $12.87 | $14.55 | +13.1% | +12.7% | -1.7% | -3.2% | +0.8% | -1.1% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.96 | $11.90 | -0.5% | +2.8% | +3.7% | -0.2% | +5.0% | -0.7% |
| May 15 | Needham | Maintains | Buy → Buy | — | $11.96 | $11.90 | -0.5% | +2.8% | +3.7% | -0.2% | +5.0% | -0.7% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $14.96 | $14.74 | -1.5% | -0.9% | +3.4% | -9.0% | -1.9% | -0.7% |
| Apr 1 | Needham | Maintains | Buy → Buy | — | $14.75 | $15.49 | +5.0% | +1.2% | +3.1% | -0.2% | -0.3% | +2.7% |
| Mar 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.73 | $15.10 | +2.5% | +4.0% | +3.8% | -2.1% | +3.0% | -0.7% |
| Mar 13 | Needham | Maintains | Buy → Buy | — | $13.98 | $14.07 | +0.6% | +5.4% | +4.0% | +3.8% | -2.1% | +3.0% |
| Feb 21 | Needham | Maintains | Buy → Buy | — | $14.13 | $14.02 | -0.8% | +0.9% | -1.5% | +2.0% | +2.1% | +0.5% |
| Jan 5 | Needham | Maintains | Buy → Buy | — | $12.26 | $12.63 | +3.0% | +3.3% | +1.6% | +2.4% | -4.1% | -1.0% |
| Dec 21 | Wedbush | Maintains | Underperform → Underperform | — | $10.70 | $11.09 | +3.6% | +5.3% | +4.4% | -1.3% | +4.9% | -1.0% |
| Dec 21 | BofA Securities | Maintains | Buy → Buy | — | $10.70 | $11.09 | +3.6% | +5.3% | +4.4% | -1.3% | +4.9% | -1.0% |
| Dec 21 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $10.70 | $11.09 | +3.6% | +5.3% | +4.4% | -1.3% | +4.9% | -1.0% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $6.80 | $6.71 | -1.3% | -4.5% | -5.6% | +2.3% | +0.9% | +0.9% |
| Aug 14 | Wedbush | Maintains | Underperform → Underperform | — | $7.17 | $7.25 | +1.1% | -2.1% | -0.7% | -0.7% | -2.2% | +2.8% |
| Aug 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.89 | $7.81 | -1.0% | -9.1% | -2.1% | -0.7% | -0.7% | -2.2% |
| Aug 10 | Needham | Maintains | Buy → Buy | — | $7.65 | $7.80 | +2.0% | +3.1% | -9.1% | -2.1% | -0.7% | -0.7% |
| Jul 31 | Needham | Maintains | Buy → Buy | — | $7.76 | $7.77 | +0.1% | -0.5% | +1.0% | +0.3% | +1.0% | +2.7% |
| Jul 25 | Needham | Maintains | Buy → Buy | — | $7.11 | $7.18 | +1.0% | -0.6% | -0.1% | +3.6% | +6.2% | -0.5% |
| Jun 28 | Needham | Maintains | Buy → Buy | — | $8.92 | $9.00 | +0.9% | +11.0% | -17.7% | -3.7% | -0.3% | +1.2% |
| May 9 | Wedbush | Maintains | Underperform → Underperform | — | $7.60 | $7.55 | -0.7% | +0.0% | -1.7% | -2.8% | +1.4% | +0.5% |
| May 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.40 | $7.50 | +1.4% | +2.7% | +0.0% | -1.7% | -2.8% | +1.4% |
| Apr 19 | Needham | Maintains | Buy → Buy | — | $6.98 | $6.92 | -0.9% | +0.3% | -3.1% | +2.4% | -2.0% | -1.5% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.22 | $7.15 | -1.0% | -1.7% | +1.4% | -4.7% | +0.4% | -0.6% |
| Mar 20 | Wedbush | Maintains | Underperform → Underperform | — | $7.22 | $7.15 | -1.0% | -1.7% | +1.4% | -4.7% | +0.4% | -0.6% |
| Mar 17 | Needham | Maintains | Buy → Buy | — | $7.33 | $7.38 | +0.7% | -1.5% | -1.7% | +1.4% | -4.7% | +0.4% |
| Feb 3 | Needham | Maintains | Buy → Buy | — | $7.01 | $7.13 | +1.7% | +1.7% | -3.2% | +1.0% | -1.6% | -0.3% |
| Sep 2 | Needham | Maintains | Buy → Buy | — | $4.86 | $5.09 | +4.8% | +20.6% | -4.1% | +3.0% | +5.9% | -0.7% |
| Sep 1 | Wedbush | Downgrade | Neutral → Underperform | — | $5.77 | $5.10 | -11.6% | -15.8% | +20.6% | -4.1% | +3.0% | +5.9% |
| Jul 22 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $5.03 | $5.15 | +2.4% | +3.4% | -1.7% | -1.0% | +6.1% | -4.7% |
| Jul 20 | BTIG | Maintains | Buy → Buy | — | $5.42 | $5.35 | -1.3% | -2.4% | -4.9% | +3.4% | -1.7% | -1.0% |
| May 26 | BofA Securities | Maintains | Buy → Buy | — | $3.65 | $3.93 | +7.7% | +10.4% | +1.0% | -0.2% | -4.2% | +12.1% |
| Feb 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.82 | $5.94 | +2.1% | +4.6% | +2.6% | +3.4% | +2.3% | +0.3% |
| Jan 10 | Needham | Maintains | Buy → Buy | — | $6.26 | $6.15 | -1.8% | +8.8% | -3.1% | -11.2% | -2.2% | +9.1% |
| Mar 23 | Needham | Maintains | Buy → Buy | — | $2.71 | $2.65 | -2.2% | -5.9% | -1.6% | +4.4% | -3.4% | -4.3% |
| Dec 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.92 | $2.97 | +1.7% | -0.7% | +0.5% | +0.5% | -3.1% | +2.5% |
| Nov 19 | Wedbush | Downgrade | Outperform → Neutral | — | $3.38 | $3.35 | -0.9% | +0.6% | -7.6% | -2.1% | +0.8% | -5.2% |
| Dec 26 | Wedbush | Maintains | Outperform → Outperform | — | $3.52 | $4.04 | +14.8% | +43.5% | -2.2% | -7.7% | -6.2% | +2.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Boyle DanaOff | Chief Accounting Officer | Sell | 1,600 | $87.53 | $140K | 167,919 | -0.02% | — |
| Jul 27, 2026 | Adair JasonOff | Chief Business Officer | Sell | 688 | $87.53 | $60K | 216,438 | -0.02% | — |
| Jul 21, 2026 | Bloch Stephen MDir | — | Sell | 556 | $80.66 | $45K | 701,477 | +2.29% | +0.00% |
| Jul 21, 2026 | Bloch Stephen MDir | — | Sell | 74,444 | $79.98 | $6.0M | 702,033 | +2.29% | +0.00% |
| Jul 20, 2026 | Bloch Stephen MDir | — | Sell | 3,596 | $79.55 | $286K | 776,477 | +2.29% | +0.00% |
| Jul 13, 2026 | Boyle DanaOff | Chief Accounting Officer | Sell | 8,361 | $71.52 | $598K | 169,519 | +1.65% | +4.94% |
| Jul 13, 2026 | Boyle DanaOff | Chief Accounting Officer | Sell | 641 | $71.39 | $46K | 177,880 | +1.65% | +4.94% |
| Jul 13, 2026 | Moomaw ScottOff | Chief Commercial Officer | Sell | 8,864 | $71.52 | $634K | 182,485 | +1.65% | +4.94% |
| Jul 13, 2026 | Moomaw ScottOff | Chief Commercial Officer | Sell | 675 | $71.39 | $48K | 191,349 | +1.65% | +4.94% |
| Jul 13, 2026 | Saggar RajeevOff | Chief Medical Officer | Sell | 9,223 | $71.52 | $660K | 171,799 | +1.65% | +4.94% |
| Jul 13, 2026 | Saggar RajeevOff | Chief Medical Officer | Sell | 703 | $71.39 | $50K | 181,022 | +1.65% | +4.94% |
| Jul 13, 2026 | Schundler RussellOff | General Counsel | Sell | 13,692 | $71.52 | $979K | 605,962 | +1.65% | +4.94% |
| Jul 13, 2026 | Schundler RussellOff | General Counsel | Sell | 1,046 | $71.39 | $75K | 619,654 | +1.65% | +4.94% |
| Jul 13, 2026 | Adair JasonOff | Chief Business Officer | Sell | 7,301 | $71.52 | $522K | 217,126 | +1.65% | +4.94% |
| Jul 13, 2026 | Adair JasonOff | Chief Business Officer | Sell | 562 | $71.39 | $40K | 224,427 | +1.65% | +4.94% |
| Jul 13, 2026 | JEFFS ROGERDir/Off | Chief Executive Officer | Sell | 32,744 | $71.52 | $2.3M | 1,130,426 | +1.65% | +4.94% |
| Jul 13, 2026 | JEFFS ROGERDir/Off | Chief Executive Officer | Sell | 2,505 | $71.39 | $179K | 1,163,170 | +1.65% | +4.94% |
| Jul 13, 2026 | Kaseta MichaelOff | CFO and COO | Sell | 18,977 | $71.52 | $1.4M | 345,805 | +1.65% | +4.94% |
| Jul 13, 2026 | Kaseta MichaelOff | CFO and COO | Sell | 1,453 | $71.39 | $104K | 364,782 | +1.65% | +4.94% |
| Jul 13, 2026 | Khindri SanjeevOff | Chief Development Officer | Sell | 1,101 | $71.52 | $79K | 65,947 | +1.65% | +4.94% |
| Jul 13, 2026 | Khindri SanjeevOff | Chief Development Officer | Sell | 84 | $71.39 | $6K | 67,048 | +1.65% | +4.94% |
| Jul 13, 2026 | Krepp SarahOff | Chief Human Resource Officer | Sell | 7,306 | $71.52 | $523K | 117,178 | +1.65% | +4.94% |
| Jul 13, 2026 | Krepp SarahOff | Chief Human Resource Officer | Sell | 558 | $71.39 | $40K | 124,484 | +1.65% | +4.94% |
| Jul 7, 2026 | Bloch Stephen MDir | — | Sell | 27,282 | $81.31 | $2.2M | 780,073 | +2.49% | +1.65% |
| Jul 7, 2026 | Bloch Stephen MDir | — | Sell | 22,718 | $80.48 | $1.8M | 807,355 | +2.49% | +1.65% |
| Jul 6, 2026 | Bloch Stephen MDir | — | Sell | 25,000 | $80.17 | $2.0M | 830,073 | +2.49% | +1.65% |
| Jul 1, 2026 | Bloch Stephen MDir | — | Sell | 853 | $80.05 | $68K | 855,073 | +2.55% | -8.62% |
| Jul 1, 2026 | Bloch Stephen MDir | — | Sell | 24,147 | $79.45 | $1.9M | 855,926 | +2.55% | -8.62% |
| Jun 22, 2026 | Bloch Stephen MDir | — | Sell | 30,500 | $76.18 | $2.3M | 880,073 | +1.83% | -0.51% |
| Jun 22, 2026 | Bloch Stephen MDir | — | Sell | 69,500 | $75.54 | $5.3M | 910,573 | +1.83% | -0.51% |
8-K · 2.02
!! High
Liquidia Corporation -- 8-K 2.02: Earnings Results
Liquidia Corporation reported Q1 2026 financial results and provided a corporate update, which investors should review for operational performance, cash position, and strategic developments affecting the biotech company's future trajectory.
May 11
8-K
Liquidia Corporation -- 8-K Filing
Liquidia Corporation has scheduled a webcast for March 5, 2026, at 8:30 a.m. ET to present financial results and provide corporate updates to investors.
Mar 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Farallon Capital Management Llc | 8,656,038 | $327M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 2,926,945 | $110M | New | Mar 2026 |
| 3 | Bank Of America Corp /de/ | 2,287,792 | $86M | Added | Mar 2026 |
| 4 | Opaleye Management Inc. | 2,435,000 | $85M | Reduced | Dec 2025 |
| 5 | Mpm Bioimpact Llc | 1,405,158 | $53M | — | Mar 2026 |
| 6 | Susquehanna International Group, Llp | 1,001,081 | $38M | Added | Mar 2026 |
| 7 | D.e. Shaw & Co | 873,065 | $33M | Reduced | Mar 2026 |
| 8 | Morgan Stanley | 947,064 | $33M | Reduced | Dec 2025 |
| 9 | Vanguard Portfolio Management Llc | 632,625 | $24M | New | Mar 2026 |
| 10 | Fmr Llc | 582,200 | $22M | Added | Mar 2026 |
| 11 | Northern Trust Corp | 579,875 | $22M | Added | Mar 2026 |
| 12 | Two Sigma Investments, Lp | 563,233 | $21M | Added | Mar 2026 |
| 13 | Invesco Ltd. | 481,446 | $18M | Added | Mar 2026 |
| 14 | Jane Street Group, Llc | 417,638 | $14M | Reduced | Dec 2025 |
| 15 | Marshall Wace, Llp | 289,439 | $11M | Added | Mar 2026 |
| 16 | First Trust Advisors Lp | 279,475 | $11M | Reduced | Mar 2026 |
| 17 | Ubs Group Ag | 207,237 | $8M | Added | Mar 2026 |
| 18 | Algert Global Llc | 204,060 | $8M | Added | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 193,920 | $7M | Reduced | Mar 2026 |
| 20 | Jpmorgan Chase & Co | 195,116 | $7M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$7.22B
Enterprise Value
$7.16B
P/E (TTM)
602.80x
Forward P/E
34.78x
PEG Ratio
0.83x
P/B
161.25x
P/S
25.05x
P/FCF
-180.30x
EV/EBITDA
133.07x
Shares Out
86.1M
Financials (TTM)
Revenue
$288.1M
Net Income
$22.3M
EBITDA
$53.8M
Free Cash Flow
-$40.0M
Op Cash Flow
-$35.7M
EPS Basic
$-0.80
EPS Diluted
$0.14
EPS Forward
$2.41
Gross Margin
91.8%
Op Margin
15.8%
Net Margin
7.7%
Balance Sheet
Total Assets
$327.9M
Total Liab.
$283.2M
Total Equity
$44.7M
Cash
$190.7M
LT Debt
$132.9M
Book Value/Sh
$0.52
Debt/Equity
4.42x
Current Ratio
1.40
Quick Ratio
1.40
Returns & Growth
ROE
-154.0%
ROA
-21.0%
ROIC
-20.5%
Rev Growth YoY
+1031.2%
EPS Growth YoY
+51.8%
Price Returns
2W
+5.2%
1M
+6.0%
3M
+120.5%
6M
+98.4%
12M
+375.7%
Technicals
52W High
$89.03
52W Low
$17.68
50d MA
$73.69
200d MA
$45.24
RSI (14)
61.10
ATR (14)
$5.50
Beta
0.46
Avg Volume
1.6M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.67
High
$55.00
Low
$47.00
Median
$50.00
Data updated apr 25, 2026 7:50pm
· Source: financialmodelingprep.com